Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (11-20 of 927) with videos related to

Pageof 93
Sort By:
Journal of the American College of Cardiology|September 6, 2008
Aggressive therapy is not always the best therapyAlbert V G Bruschke, J Wouter Jukema
European Heart Journal|August 23, 2013
High coronary plaque load: a heavy burdenMichiel A de Graaf, J Wouter Jukema
Current Opinion in Lipidology|January 4, 2018
Plasma apolipoprotein-B is an important risk factor for cardiovascular disease, and its assessment should be routine clinical practiceStella Trompet, Chris J Packard, J Wouter Jukema
Current Opinion in Lipidology|April 21, 2017
Increasing HDL-C levels with medication: current perspectivesRoelof Aj Smit, J Wouter Jukema, Stella Trompet
Aging|December 13, 2019
PCSK9 inhibition in high-risk patientsLaurien E Zijlstra, Simon P Mooijaart, J Wouter Jukema
Expert Opinion on Pharmacotherapy|March 5, 2004
Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapyJ Wouter Jukema, José W A van der Hoorn
Circulation. Cardiovascular Quality and Outcomes|May 16, 2013
Journey through cholesteryl ester transfer protein inhibition: from bench to bedsideIoannis Karalis, Patrick C N Rensen, J Wouter Jukema
Expert Opinion on Emerging Drugs|January 14, 2011
Emerging drugs for coronary artery disease. From past achievements and current needs to clinical promisesTarek A N Ahmed, Ioannis Karalis, J Wouter Jukema
Current Medical Research and Opinion|December 21, 2011
Antiplatelet therapy in patients with ST-elevation myocardial infarction undergoing myocardial revascularisation: beyond clopidogrelJ Wouter Jukema, Jean-Philippe Collet, Leonardo De Luca
Annals of Translational Medicine|October 22, 2014
Statins reduce the risk of cancer-related mortality in cancer-diagnosed patients. A true phenomenon?Stella Trompet, Anton Jm de Craen, J Wouter Jukema
Pageof 93

Showing results (11-20 of 927) with videos related to

Sort By:
Pageof 93
Journal of the American College of Cardiology|September 6, 2008
Aggressive therapy is not always the best therapyAlbert V G Bruschke, J Wouter Jukema
European Heart Journal|August 23, 2013
High coronary plaque load: a heavy burdenMichiel A de Graaf, J Wouter Jukema
Current Opinion in Lipidology|January 4, 2018
Plasma apolipoprotein-B is an important risk factor for cardiovascular disease, and its assessment should be routine clinical practiceStella Trompet, Chris J Packard, J Wouter Jukema
Current Opinion in Lipidology|April 21, 2017
Increasing HDL-C levels with medication: current perspectivesRoelof Aj Smit, J Wouter Jukema, Stella Trompet
Aging|December 13, 2019
PCSK9 inhibition in high-risk patientsLaurien E Zijlstra, Simon P Mooijaart, J Wouter Jukema
Expert Opinion on Pharmacotherapy|March 5, 2004
Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapyJ Wouter Jukema, José W A van der Hoorn
Circulation. Cardiovascular Quality and Outcomes|May 16, 2013
Journey through cholesteryl ester transfer protein inhibition: from bench to bedsideIoannis Karalis, Patrick C N Rensen, J Wouter Jukema
Expert Opinion on Emerging Drugs|January 14, 2011
Emerging drugs for coronary artery disease. From past achievements and current needs to clinical promisesTarek A N Ahmed, Ioannis Karalis, J Wouter Jukema
Current Medical Research and Opinion|December 21, 2011
Antiplatelet therapy in patients with ST-elevation myocardial infarction undergoing myocardial revascularisation: beyond clopidogrelJ Wouter Jukema, Jean-Philippe Collet, Leonardo De Luca
Annals of Translational Medicine|October 22, 2014
Statins reduce the risk of cancer-related mortality in cancer-diagnosed patients. A true phenomenon?Stella Trompet, Anton Jm de Craen, J Wouter Jukema
Pageof 93